RETATRUTIDE 60 MG PEN BRETATRUTIDE 60 MG MULTI USE
₹ 18,000/PieceRetatrutide 60mg Pen refers to an investigational, injectable medication for weight loss, a triple-agonist targeting GIP, GLP-1, and glucagon receptors, showing significant weight reduction in trials by reducing appetite and increasing metabolism, available in pre-filled pens for weekly subcutaneous use, though still under development and not yet FDA-approved for general use. Suppliers in India offer it in pen form for research/export, often citing 12mg strength pens with potential doses up to 60mg or more, mimicking similar drugs like Ozempic but with a triple-hormone approach for potentially greater efficacy. What it is
A Triple-Agonist: It mimics three natural gut hormones (GIP, GLP-1, and glucagon) to control hunger, slow digestion, and boost fat burning.
Investigational Drug: Still in clinical trials (Phase 3), not approved by regulatory bodies like the FDA for public use yet.
How it's used
Weekly Injection: Administered once a week under the skin (subcutaneously).
Pen Device: Comes in a pen format for easier dosing, similar to Ozempic or Mounjaro.
Dosage: Doses studied range from 1mg to 12mg, with higher doses potentially leading to greater weight loss.
What it does
Significant Weight Loss: Phase 2 trials showed average weight loss of over 20% in 48 weeks.
Metabolic Benefits: Improves blood sugar, insulin, and lipid levels.
Lancer HealthcareChandni Chowk, New Delhi
Verified Exporter
WhatsApp
Call Now
+917942658349
